SAMSUNG PHARM. Co., LTD. (KRX:001360)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2012	FY 2011	FY 2010
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Pharmaceutical			42.91B	39.07B	40.53B			-	-
Pharmaceutical Growth			9.85%	-3.61%	-			-	-
Health Food			3.72B	3.03B	7.10B			-	-
Health Food Growth			22.71%	-57.33%	-			-	-
Consolidated Adjustments			-144.64M	-	-431.72M			-	-
Manufacturing and Sales of Pharmaceutical Drugs			-	-	-			47.29B	44.08B
Manufacturing and Sales of Pharmaceutical Drugs Growth			-	-	-			7.28%	12.32%
Total			46.48B	42.09B	47.19B			47.29B	44.08B
Total Growth			10.43%	-10.81%	-			7.28%	12.32%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2012	FY 2011	FY 2010
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
South Korea			-	-	-			47.29B	44.08B
South Korea Growth			-	-	-			7.28%	-
Total			-	-	-			47.29B	44.08B
Total Growth			-	-	-			7.28%	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2019

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 12, 2026

Data Sources Report a data error